Insider Transactions in Q4 2024 at Elevance Health, Inc. (ELV)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 01
2024
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
BUY
Grant, award, or other acquisition
|
Direct |
3,799
+15.3%
|
-
|
|
Nov 01
2024
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Payment of exercise price or tax liability
|
Direct |
1,649
-8.73%
|
$682,686
$414.01 P/Share
|
|
Nov 01
2024
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
1,710
+15.55%
|
-
|
|
Nov 01
2024
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
846
-10.04%
|
$350,244
$414.01 P/Share
|
|
Oct 18
2024
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
SELL
Open market or private sale
|
Direct |
7,417
-46.82%
|
$3,204,144
$432.14 P/Share
|
|
Oct 02
2024
|
Mark Kaye EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,818
-12.24%
|
$1,423,090
$505.16 P/Share
|